title: Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
authors.forename: M
authors.initials: M
authors.lastname: Viigimaa
authors.forename: K
authors.initials: K
authors.lastname: Allikmets
authors.forename: T
authors.initials: T
authors.lastname: Parik
authors.forename: J
authors.initials: J
authors.lastname: Skards
authors.forename: A
authors.initials: A
authors.lastname: Franken
authors.forename: G
authors.initials: G
authors.lastname: Häss
mesh_terms: D000704:Analysis of Variance; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004338:Drug Combinations; D004656:Enalapril / Q000627:therapeutic use*; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D000804:Angiotensin II; C086167:tasosartan; D004656:Enalapril